Aventis Daptacel Ordering Will Begin For Existing DTaP Customers May 28
Executive Summary
Aventis Pasteur will begin taking orders for the diphtheria, tetanus and acellular pertussis vaccine Daptacel from existing DTaP customers May 28
You may also be interested in...
Aventis Alvesco For Asthma Is One Of Five NDA/BLA Filings Planned For 2003
Aventis is planning a third quarter NDA filing for the asthma therapy Alvesco, one of up to five novel agents the company expects to reach the filing stage by early 2004
Aventis Alvesco For Asthma Is One Of Five NDA/BLA Filings Planned For 2003
Aventis is planning a third quarter NDA filing for the asthma therapy Alvesco, one of up to five novel agents the company expects to reach the filing stage by early 2004
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply